-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
hDHODH-IN-3
Category | Influenza Virus |
CAS | 1644156-80-8 |
Description | hDHODH-IN-3, a human dihydroorotate dehydrogenase inhibitor, inhibits measles virus replication with a pMIC50 of 8.6. |
Product Information
Synonyms | DHODH-IN-2; 2-[4-(2-Bromophenoxy)-3-ethoxy-5-methyl-1H-pyrazol-1-yl]-5-ethylpyrimidine; Pyrimidine, 2-[4-(2-bromophenoxy)-3-ethoxy-5-methyl-1H-pyrazol-1-yl]-5-ethyl- |
IUPAC Name | 2-[4-(2-bromophenoxy)-3-ethoxy-5-methylpyrazol-1-yl]-5-ethylpyrimidine |
Molecular Weight | 403.27 |
Molecular Formula | C18H19BrN4O2 |
Canonical SMILES | CCC1=CN=C(N=C1)N2C(=C(C(=N2)OCC)OC3=CC=CC=C3Br)C |
InChI | InChI=1S/C18H19BrN4O2/c1-4-13-10-20-18(21-11-13)23-12(3)16(17(22-23)24-5-2)25-15-9-7-6-8-14(15)19/h6-11H,4-5H2,1-3H3 |
InChIKey | SNDPFEDGFPXNIX-UHFFFAOYSA-N |
Boiling Point | 528.9±60.0°C at 760 mmHg |
Purity | ≥95% |
Density | 1.4±0.1 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | White to off-white (Solid) |
Storage | Store at -20°C |
Complexity | 409 |
Exact Mass | 402.06914 |
In Vitro | In self-organizing molecular field analysis (SOMFA), hDHODH-IN-2 (compound 42) had log 1/IC50s of 5.83 and 5.80 for DODH in rats and mice, respectively. |
Target | Dihydroorotate Dehydrogenase; DNA/RNA Synthesis; Influenza Virus |
XLogP3-AA | 4.6 |